StockData
Cardinal Health Inc logo

Cardinal Health Inc (CAH) stock

CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3043% above fair value
$283.85+2.75 (+0.98%)

Close on Nov 16, 2026Market cap $66.02BP/E 39.3Yield 0.72%

Cardinal Health r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Cardinal Health

Cardinal Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cardinal Health figures

See a number that looks wrong?